| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.28 | 0.3 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |